Xeris Biopharma Holdings, Inc. (XERS)

6.12 -0.08 (-1.29%) USD  |  NASDAQ  |  Apr 16, 16:00
6.13 +0.01 (+0.16%) After-Hours: 20:00
More

Xeris Biopharma Holdings Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
IDEXX Laboratories, Inc. Upgrade
Zoetis, Inc. Upgrade
Harrow, Inc. Upgrade
Zymeworks, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade